232 related articles for article (PubMed ID: 30944244)
1. IFN-γ is a therapeutic target in paraneoplastic cerebellar degeneration.
Yshii L; Pignolet B; Mauré E; Pierau M; Brunner-Weinzierl M; Hartley O; Bauer J; Liblau R
JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30944244
[TBL] [Abstract][Full Text] [Related]
2. Immunological Bases of Paraneoplastic Cerebellar Degeneration and Therapeutic Implications.
Yshii L; Bost C; Liblau R
Front Immunol; 2020; 11():991. PubMed ID: 32655545
[TBL] [Abstract][Full Text] [Related]
3. Anti-Yo antibody uptake and interaction with its intracellular target antigen causes Purkinje cell death in rat cerebellar slice cultures: a possible mechanism for paraneoplastic cerebellar degeneration in humans with gynecological or breast cancers.
Greenlee JE; Clawson SA; Hill KE; Wood B; Clardy SL; Tsunoda I; Carlson NG
PLoS One; 2015; 10(4):e0123446. PubMed ID: 25885452
[TBL] [Abstract][Full Text] [Related]
4. Paraneoplastic cerebellar degeneration: Yo antibody alters mitochondrial calcium buffering capacity.
Panja D; Vedeler CA; Schubert M
Neuropathol Appl Neurobiol; 2019 Feb; 45(2):141-156. PubMed ID: 29679372
[TBL] [Abstract][Full Text] [Related]
5. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice.
Tanaka K; Tanaka M; Igarashi S; Onodera O; Miyatake T; Tsuji S
Clin Neurol Neurosurg; 1995 Feb; 97(1):101-5. PubMed ID: 7788964
[TBL] [Abstract][Full Text] [Related]
6. Induction of humoral responses specific for paraneoplastic cerebellar degeneration-associated antigen by whole recombinant yeast immunization.
Saiki M; Sakai K; Saiki S; Kitagawa Y; Nakanishi M; Hirose G
J Autoimmun; 2005 May; 24(3):203-8. PubMed ID: 15848042
[TBL] [Abstract][Full Text] [Related]
7. Morphological and immunohistochemical characterization of paraneoplastic cerebellar degeneration associated with Yo antibodies.
Storstein A; Krossnes BK; Vedeler CA
Acta Neurol Scand; 2009 Jul; 120(1):64-7. PubMed ID: 19486326
[TBL] [Abstract][Full Text] [Related]
8. Paraneoplastic CDR2 and CDR2L antibodies affect Purkinje cell calcium homeostasis.
Schubert M; Panja D; Haugen M; Bramham CR; Vedeler CA
Acta Neuropathol; 2014 Dec; 128(6):835-52. PubMed ID: 25341622
[TBL] [Abstract][Full Text] [Related]
9. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with gastric adenocarcinoma.
Meglic B; Graus F; Grad A
J Neurol Sci; 2001 Apr; 185(2):135-8. PubMed ID: 11311295
[TBL] [Abstract][Full Text] [Related]
10. CTLA4 blockade elicits paraneoplastic neurological disease in a mouse model.
Yshii LM; Gebauer CM; Pignolet B; Mauré E; Quériault C; Pierau M; Saito H; Suzuki N; Brunner-Weinzierl M; Bauer J; Liblau R
Brain; 2016 Nov; 139(11):2923-2934. PubMed ID: 27604307
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies in paraneoplastic cerebellar degeneration bind to cytoplasmic antigens of Purkinje cells in humans, rats and mice and are of multiple immunoglobulin classes.
Smith JL; Finley JC; Lennon VA
J Neuroimmunol; 1988 Apr; 18(1):37-48. PubMed ID: 3346369
[TBL] [Abstract][Full Text] [Related]
12. Paraneoplastic cerebellar syndromes associated with antibodies against Purkinje cells.
Schwenkenbecher P; Chacko L; Pul R; Sühs KW; Wegner F; Wurster U; Stangel M; Skripuletz T
Int J Neurosci; 2018 Aug; 128(8):721-728. PubMed ID: 29199513
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigen.
Jaeckle KA; Graus F; Houghton A; Cardon-Cardo C; Nielsen SL; Posner JB
Ann Neurol; 1985 Nov; 18(5):592-600. PubMed ID: 2416270
[TBL] [Abstract][Full Text] [Related]
14. A Pilot Study to Develop Paraneoplastic Cerebellar Degeneration Mouse Model.
Faure F; Yshii L; Renno T; Coste I; Joubert B; Desestret V; Liblau R; Honnorat J
Cerebellum; 2024 Feb; 23(1):181-196. PubMed ID: 36729270
[TBL] [Abstract][Full Text] [Related]
15. [Paraneoplastic cerebellar degeneration associated with ovarian cancer: anti-Yo immunoreactivity in autoptic cerebellum and ovarian carcinoma].
Bartos A; Stourac P; Rusina R; Sejdová M; Velenská Z
Nervenarzt; 2002 Oct; 73(10):995-8. PubMed ID: 12376889
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic T cells against a peptide of Yo protein in patients with paraneoplastic cerebellar degeneration and anti-Yo antibody.
Tanaka M; Tanaka K; Tokiguchi S; Shinozawa K; Tsuji S
J Neurol Sci; 1999 Sep; 168(1):28-31. PubMed ID: 10500270
[TBL] [Abstract][Full Text] [Related]
17. Neurologic improvement after high-dose intravenous immunoglobulin therapy in patients with paraneoplastic cerebellar degeneration associated with anti-Purkinje cell antibody.
Phuphanich S; Brock C
J Neurooncol; 2007 Jan; 81(1):67-9. PubMed ID: 16773214
[TBL] [Abstract][Full Text] [Related]
18. Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration.
Albert ML; Austin LM; Darnell RB
Ann Neurol; 2000 Jan; 47(1):9-17. PubMed ID: 10632096
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase Cgamma autoimmunity in paraneoplastic cerebellar degeneration and non-small-cell lung cancer.
Sabater L; Bataller L; Carpentier AF; Aguirre-Cruz ML; Saiz A; Benyahia B; Dalmau J; Graus F
J Neurol Neurosurg Psychiatry; 2006 Dec; 77(12):1359-62. PubMed ID: 16801349
[TBL] [Abstract][Full Text] [Related]
20. Restricted IgG1 subclass of anti-Yo antibodies in paraneoplastic cerebellar degeneration.
Amyes E; Curnow J; Stark Z; Corlett L; Sutton I; Vincent A
J Neuroimmunol; 2001 Mar; 114(1-2):259-64. PubMed ID: 11240040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]